Option Care Health, Inc.(OPCH)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #1,021 of 2,879 stocksTOP 50%
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
OPCH Stock Analysis & AI Quality Score
AI stock analysis and institutional research for Option Care Health, Inc. (OPCH), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores OPCH at 57.8/100 on a 32-signal composite quality model, placing it at rank #1,021 of 2,879 stocks — the top half of the AI-ranked universe. OPCH scores in the top quartile across revenue scale (79.2). Areas of concern include institutional flow (16.9) and earnings quality (24.7), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q1 2026), Option Care Health, Inc. reports quarterly revenue of $1.4B, net income of $45.3M, an operating margin of 5.4%. Top institutional holders of OPCH by reported 13-F value include BlackRock,, WELLINGTON MANAGEMENT GROUP LLP, Durable Capital Partners, based on the most recent SEC filings. OPCH trades on the Nasdaq exchange and files with the SEC under CIK 1014739. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate OPCH daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Option Care Health, Inc. directly from SEC EDGAR. Option Care Health, Inc.'s 13F Pro composite quality score has ranged between 8 and 73 since 2021, currently 57.8 — an improving long-term trajectory across 56 quarterly and live scoring snapshots.
Revenue
Q1 2026
$1.4B
Net Income
Q1 2026
$45.3M
Free Cash Flow
Q1 2026
$-21.2M
Operating Margin
Q1 2026
5.4%
D/E Ratio
Q1 2026
0.86
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · Pro+Revenue
+13.0% YoYNet Income
-2.0% YoYOperating Income
+5.0% YoYEPS (Diluted)
+3.3% YoYTotal Assets
+1.0% YoYTotal Debt
+4.5% YoYOp. Cash Flow
-20.1% YoY| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $5.65B +13.0% | $5.00B +16.2% | $4.30B +9.1% | $3.94B +14.7% | $3.44B +13.4% | $3.03B |
| Net Income | $207.6M -2.0% | $211.8M -20.7% | $267.1M +77.4% | $150.6M +7.6% | $139.9M +1832.3% | $-8.1M |
| Operating Income | $337.9M +5.0% | $321.8M +2.3% | $314.6M +31.0% | $240.2M +25.9% | $190.8M +72.3% | $110.8M |
| EPS (Diluted) | $1.27 +3.3% | $1.23 -16.9% | $1.48 +78.3% | $0.83 +7.8% | $0.77 +2025.0% | $-0.04 |
| Total Assets | $3.46B +1.0% | $3.42B +6.4% | $3.22B +3.3% | $3.11B +11.5% | $2.79B +5.4% | $2.65B |
| Total Debt | $1.17B +4.5% | $1.12B +4.6% | $1.07B -0.1% | $1.07B -0.2% | $1.07B -5.4% | $1.13B |
| Operating Cash Flow | $258.4M -20.1% | $323.4M -12.9% | $371.3M +38.8% | $267.5M +28.3% | $208.6M +63.7% | $127.4M |
AI Insight: OPCH Financial Trends
Revenue growth stalls in Q1 2026 with operating income hitting a 7-quarter low of $73M, while operating cash flow turns negative for the second consecutive Q1.
• Revenue grew 10.1% year-over-year from $1,227M in Q2 2024 to $1,351M in Q1 2026, but sequential momentum has stalled.
• Operating income contracted to $73M in Q1 2026, below the $79M in Q1 2025 and the lowest reading in the dataset.
• Operating cash flow turned negative at -$12M in Q1 2026, worse than -$7M in Q1 2025, suggesting a recurring seasonal cash drag.
• Total debt edged up to $1,167–1,169M in the last two quarters after holding flat at $1,117–1,119M for four quarters.
⚠ Q1 operating cash flow has been negative in both 2025 and 2026; monitor whether this seasonal pattern worsens in magnitude.
⚠ Equity has declined from $1,426M in Q3 2024 to $1,326M in Q4 2025, a $100M erosion — watch for further deterioration.
⚠ Debt increased by ~$51M in Q3 2025 and remains elevated; any further step-ups could pressure the balance sheet.
AI Insight: OPCH Ratio Trends
Q1 2026 marks the weakest quarter in the dataset, with ROIC dropping to 11.5% and operating margin hitting a new low of 5.4%.
• Operating margin declined from a peak of 6.7% in Q3 2024 to 5.4% in Q1 2026, the lowest in the observed period.
• ROIC fell sharply to 11.5% in Q1 2026 from 14.7% in Q4 2025, reversing a multi-quarter high.
• D/E ratio has drifted upward from 0.78 in Q3 2024 to 0.88 in Q4 2025, signaling modestly rising leverage.
• Q4 quarters consistently show stronger ROE (17.1% in Q4 2024; 17.6% in Q4 2025), suggesting pronounced seasonality.
⚠ ROIC dropped 3.2pp quarter-over-quarter to 11.5% in Q1 2026 — the steepest single-quarter decline in the dataset.
⚠ Net profit margin compressed to 3.4% in Q1 2026; sustained pressure below 3.5% would indicate structural deterioration.
⚠ D/E at 0.88 in Q4 2025 is the highest recorded; monitor whether leverage continues climbing into 2026.
Get alerted when OPCH's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for Option Care Health, Inc. including:
Top Institutional Holders of OPCH
BlackRock, Inc.
$535.4M19,887,832 shWELLINGTON MANAGEMENT GROUP LLP
$320.3M11,897,467 shDurable Capital Partners LP
$242.0M8,991,254 shVANGUARD PORTFOLIO MANAGEMENT LLC
$217.0M8,062,555 shFULLER & THALER ASSET MANAGEMENT, INC.
$191.8M7,125,280 shVANGUARD CAPITAL MANAGEMENT LLC
$188.9M7,016,323 shFMR LLC
$173.0M6,426,119 shSTATE STREET CORP
$158.2M5,874,880 shGEODE CAPITAL MANAGEMENT, LLC
$114.4M4,248,221 shARROWSTREET CAPITAL, LIMITED PARTNERSHIP
$114.0M4,236,237 sh
| Fund | Value | Shares |
|---|---|---|
| BlackRock, Inc. | $535.4M | 19,887,832 |
| WELLINGTON MANAGEMENT GROUP LLP | $320.3M | 11,897,467 |
| Durable Capital Partners LP | $242.0M | 8,991,254 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $217.0M | 8,062,555 |
| FULLER & THALER ASSET MANAGEMENT, INC. | $191.8M | 7,125,280 |
| VANGUARD CAPITAL MANAGEMENT LLC | $188.9M | 7,016,323 |
| FMR LLC | $173.0M | 6,426,119 |
| STATE STREET CORP | $158.2M | 5,874,880 |
| GEODE CAPITAL MANAGEMENT, LLC | $114.4M | 4,248,221 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $114.0M | 4,236,237 |
More Healthcare Companies
View all Healthcare →Put OPCH on your watchlist
Track score changes the day Option Care Health, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is OPCH a good stock to buy?
13F Pro's AI-powered analysis of Option Care Health, Inc. (OPCH) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for OPCH are available on the OPCH stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own OPCH?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling OPCH. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Option Care Health, Inc.'s investment landscape.